Perillat L, McFadyen A, Furlong P, Anderson J
Front Med (Lausanne). 2025; 12:1493832.
PMID: 39981075
PMC: 11841388.
DOI: 10.3389/fmed.2025.1493832.
Chwalenia K, Wood M, Roberts T
J Muscle Res Cell Motil. 2025; .
PMID: 39883376
DOI: 10.1007/s10974-024-09688-2.
Southern W, Johnson E, Fasbender E, Fallon K, Cavazos C, Lowe D
J Clin Invest. 2025; 135(5).
PMID: 39808494
PMC: 11870723.
DOI: 10.1172/JCI176942.
Agdamag A, Nandar P, Tang W
Curr Treat Options Cardiovasc Med. 2025; 26(8):255-270.
PMID: 39777119
PMC: 11706575.
DOI: 10.1007/s11936-024-01046-2.
Schreiber J, Rotard L, Tourneur Y, Lafoux A, Berthier C, Allard B
J Gen Physiol. 2024; 157(2).
PMID: 39718509
PMC: 11668172.
DOI: 10.1085/jgp.202413588.
Epigenetic control of myogenic identity of human muscle stem cells in Duchenne muscular dystrophy.
Massenet J, Weiss-Gayet M, Bandukwala H, Bouchereau W, Gobert S, Magnan M
iScience. 2024; 27(12):111350.
PMID: 39650736
PMC: 11625291.
DOI: 10.1016/j.isci.2024.111350.
PTPN1/2 inhibition promotes muscle stem cell differentiation in Duchenne muscular dystrophy.
Liu Y, Li S, Robertson R, Granet J, Aubry I, Filippelli R
Life Sci Alliance. 2024; 8(1).
PMID: 39477543
PMC: 11527974.
DOI: 10.26508/lsa.202402831.
Uncovering the Embryonic Origins of Duchenne Muscular Dystrophy.
Barrett P, Louie K, Dupont J, Mack D, Maves L
WIREs Mech Dis. 2024; 16(6):e1653.
PMID: 39444092
PMC: 11563919.
DOI: 10.1002/wsbm.1653.
Molecular basis of proteolytic cleavage regulation by the extracellular matrix receptor dystroglycan.
Anderson M, Hayward A, Smiley A, Shi K, Pawlak M, Aird E
Structure. 2024; 32(11):1984-1996.e5.
PMID: 39305901
PMC: 11560575.
DOI: 10.1016/j.str.2024.08.019.
Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy.
Earl C, Javier A, Richards A, Markham L, Goergen C, Welc S
Dis Model Mech. 2024; 17(10).
PMID: 39268580
PMC: 11488649.
DOI: 10.1242/dmm.050852.
Muscular dystrophy patients show low exercise-induced blood flow in muscles with normal strength.
Gera O, Shavit-Stein E, Amichai T, Chapman J, Chorin O, Greenbaum L
Ann Clin Transl Neurol. 2024; 11(11):2866-2876.
PMID: 39250335
PMC: 11572729.
DOI: 10.1002/acn3.52194.
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy.
Slick R, Sutton J, Haberman M, OBrien B, Tinklenberg J, Mardikar A
Biol Open. 2024; 13(9).
PMID: 39158383
PMC: 11391821.
DOI: 10.1242/bio.060542.
Therapeutic targeting of RNA for neurological and neuromuscular disease.
Bubenik J, Scotti M, Swanson M
Genes Dev. 2024; 38(15-16):698-717.
PMID: 39142832
PMC: 11444190.
DOI: 10.1101/gad.351612.124.
Recent Advances in Pre-Clinical Development of Adiponectin Receptor Agonist Therapies for Duchenne Muscular Dystrophy.
Gandhi S, Sweeney G, Perry C
Biomedicines. 2024; 12(7).
PMID: 39061981
PMC: 11274162.
DOI: 10.3390/biomedicines12071407.
Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response.
Gandhi S, Sweeney H, Hart C, Han R, Perry C
Cells. 2024; 13(14.
PMID: 39056750
PMC: 11274633.
DOI: 10.3390/cells13141168.
Split intein-mediated protein trans-splicing to express large dystrophins.
Tasfaout H, Halbert C, McMillen T, Allen J, Reyes T, Flint G
Nature. 2024; 632(8023):192-200.
PMID: 39020181
PMC: 11335042.
DOI: 10.1038/s41586-024-07710-8.
SERCA2a overexpression improves muscle function in a canine Duchenne muscular dystrophy model.
Kodippili K, Hakim C, Burke M, Yue Y, Teixeira J, Zhang K
Mol Ther Methods Clin Dev. 2024; 32(2):101268.
PMID: 38911286
PMC: 11190715.
DOI: 10.1016/j.omtm.2024.101268.
Two operational modes of atomic force microscopy reveal similar mechanical properties for homologous regions of dystrophin and utrophin.
Hua C, Slick R, Vavra J, Muretta J, Ervasti J, Salapaka M
bioRxiv. 2024; .
PMID: 38826288
PMC: 11142110.
DOI: 10.1101/2024.05.18.593686.
Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model.
Roger A, Biswas D, Huston M, Le D, Bailey A, Pucci L
Respir Physiol Neurobiol. 2024; 326:104282.
PMID: 38782084
PMC: 11472894.
DOI: 10.1016/j.resp.2024.104282.
Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy.
Kiperman T, Ma K
Int J Mol Sci. 2024; 25(9).
PMID: 38731986
PMC: 11083552.
DOI: 10.3390/ijms25094767.